Glaukos
$50.20
$50.20
-$0.16 (-0.33%) As of 6:18 PM UTC today
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
CEOThomas William Burns
CEOThomas William Burns
Employees727
Employees727
HeadquartersSan Clemente, California
HeadquartersSan Clemente, California
Founded1998
Founded1998
Employees727
Employees727
GKOS Key Statistics
Market cap2.38B
Market cap2.38B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume621.63K
Average volume621.63K
High today$51.43
High today$51.43
Low today$50.14
Low today$50.14
Open price$50.63
Open price$50.63
Volume330.52K
Volume330.52K
52 Week high$64.49
52 Week high$64.49
52 Week low$33.33
52 Week low$33.33
Analyst ratings
50%
of 10 ratingsBuy
40%
Hold
50%
Sell
10%
GKOS Earnings
-$0.83
-$0.56
-$0.29
-$0.02
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated-$0.44 per share
Estimated-$0.44 per share
Actual-$0.83 per share
Actual-$0.83 per share